
How does Australia’s pharmaceutical industry compare to Canada’s? We have a lot of generics here in Canada… I’m curious whether Australia would benefit from a similar stance that favours more white label production, or if Australia is more invested in the development side and feels like it needs to maintain more strict/homogenized w/ US laws to keep them as a seller and recoup on its investments.
See, that detail actually helps me understand why they might complain. But their reframing of the issue as ‘French is an illegal barrier’ will absolutely send every Canadian on the defence.